ETR:EVT - Evotec Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: €36.25
  • Forecasted Upside: -1.41 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
▼ -0.11 (-0.30%)

This chart shows the closing price for EVT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Evotec Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EVT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EVT

Analyst Price Target is €36.25
▼ -1.41% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Evotec in the last 3 months. The average price target is €36.25, with a high forecast of €40.00 and a low forecast of €33.00. The average price target represents a -1.41% upside from the last price of €36.77.

This chart shows the closing price for EVT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 investment analysts is to buy stock in Evotec. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/16/2021Warburg ResearchSet Price TargetBuy€40.00
5/19/2021Royal Bank of CanadaSet Price TargetBuy€39.00
5/12/2021Deutsche Bank AktiengesellschaftSet Price TargetNeutral€33.00
5/11/2021Baader BankSet Price TargetBuy€33.00
5/11/2021Royal Bank of CanadaSet Price TargetBuy€39.00
5/7/2021Warburg ResearchSet Price TargetBuy€40.00
4/22/2021Deutsche Bank AktiengesellschaftSet Price TargetNeutral€33.00
4/20/2021Royal Bank of CanadaSet Price TargetNeutral€32.00
3/25/2021Warburg ResearchSet Price TargetBuy€36.00
3/25/2021Baader BankSet Price TargetBuy€33.00
3/22/2021Royal Bank of CanadaSet Price TargetNeutral€32.00
2/4/2021Baader BankSet Price TargetBuy€33.00
2/3/2021Warburg ResearchSet Price TargetBuy€36.00
1/28/2021Royal Bank of CanadaSet Price TargetNeutral€32.00
1/21/2021Baader BankSet Price TargetBuy€33.00
1/19/2021Deutsche Bank AktiengesellschaftSet Price TargetNeutral€29.00
1/5/2021Baader BankSet Price TargetBuy€28.00
12/17/2020Royal Bank of CanadaSet Price TargetBuy€32.00
12/17/2020Baader BankSet Price TargetBuy€28.00
12/11/2020Warburg ResearchSet Price TargetBuy€33.00
11/20/2020Royal Bank of CanadaSet Price TargetBuy€32.00
11/13/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€28.00
11/12/2020Baader BankSet Price TargetBuy€28.00
11/12/2020Royal Bank of CanadaSet Price TargetBuy€30.00
10/20/2020Baader BankSet Price TargetBuy€28.00
10/14/2020Baader BankSet Price TargetBuy€28.00
10/13/2020Royal Bank of CanadaSet Price TargetBuy€30.00
10/9/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€28.00
10/8/2020Baader BankSet Price TargetBuy€28.00
9/9/2020Royal Bank of CanadaSet Price TargetBuy€30.00
8/18/2020Baader BankSet Price TargetBuy€28.00
7/30/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€28.00
7/21/2020Baader BankSet Price TargetBuy€28.00
6/23/2020Baader BankSet Price TargetBuy€28.00
6/15/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€28.00
6/9/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€28.00
5/18/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€28.00
5/12/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€28.00
3/27/2020Berenberg BankSet Price TargetBuy€33.00
3/27/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€28.00
3/12/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€28.00
1/28/2020Berenberg BankSet Price TargetBuy€33.00
1/23/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€25.00
1/16/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€25.00
1/10/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€25.00
12/4/2019Berenberg BankSet Price TargetBuy€28.00
11/25/2019Berenberg BankSet Price TargetBuy€28.00
11/14/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€25.00
11/12/2019Berenberg BankSet Price TargetBuy€28.00
11/8/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€25.00
10/22/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€25.00
9/25/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€25.00
9/12/2019Berenberg BankSet Price TargetBuy€28.00
9/5/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€25.00
8/22/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€25.00
8/15/2019Deutsche Bank AktiengesellschaftSet Price TargetNeutral€25.00
8/1/2019Berenberg BankSet Price TargetNeutral€28.00
5/22/2019Berenberg BankSet Price TargetNeutral€20.00
5/17/2019Deutsche Bank AktiengesellschaftSet Price TargetNeutral€23.00
5/7/2019Deutsche Bank AktiengesellschaftSet Price TargetNeutral€23.00
4/10/2019Deutsche Bank AktiengesellschaftSet Price TargetNeutral€23.00
3/5/2019Berenberg BankSet Price TargetNeutral€20.00
12/10/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy€22.00
11/15/2018Oddo BhfSet Price TargetBuy€26.00
11/14/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy€21.00
11/8/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy€21.00
9/7/2018Berenberg BankSet Price TargetNeutral€20.00
9/5/2018Oddo BhfSet Price TargetBuy€26.00
8/13/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy€21.00
8/10/2018Oddo BhfSet Price TargetBuy€22.00
8/9/2018Berenberg BankSet Price TargetNeutral€14.00
7/26/2018Oddo BhfSet Price TargetBuy€22.00
6/12/2018Oddo BhfSet Price TargetBuy€22.00
4/3/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy€20.00
3/28/2018Berenberg BankSet Price TargetNeutral€16.00
3/8/2018Berenberg BankSet Price TargetNeutral€16.00
3/7/2018Oddo BhfSet Price TargetBuy€20.00
12/7/2017Berenberg BankSet Price TargetNeutral€16.00
12/5/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy€17.00
11/29/2017Oddo BhfSet Price TargetBuy€20.00
11/9/2017Oddo BhfSet Price TargetBuy€20.00
11/8/2017Berenberg BankSet Price TargetNeutral€16.00
11/6/2017Deutsche Bank AktiengesellschaftSet Price TargetNeutral€17.00
9/19/2017Berenberg BankSet Price TargetNeutral€16.00
8/30/2017Deutsche Bank AktiengesellschaftSet Price TargetNeutral€16.00
8/21/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy€16.00
8/17/2017Berenberg BankSet Price TargetNeutral€16.00
8/14/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy€16.00
8/11/2017Oddo SecuritiesSet Price TargetNeutral€14.00
8/10/2017Berenberg BankSet Price TargetNeutral€13.00
8/7/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy€16.00
7/31/2017Berenberg BankSet Price TargetNeutral€13.00
6/6/2017Berenberg BankSet Price TargetNeutral€13.00
5/29/2017Berenberg BankSet Price TargetBuy€9.50
(Data available from 6/23/2016 forward)
Evotec logo
Evotec SE provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company's EVT Execute segment offers drug discovery services, such as target identification and validation, hit identification, sample management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, bio-reagents, in vitro biology, in vivo pharmacology, biomarkers, and antibody discovery; INDiGO, a program for accelerating drug development; integrated chemistry, manufacturing, and control services; integrated drug discovery services; and integrated pre-clinical development services. Its EVT Innovate segment is involved in developing drug discovery projects, assets, and platforms. The company's portfolio of research and development programs include diabetes and diabetic complications, fibrosis, immunology, infectious and inflammatory diseases, kidney and liver diseases, oncological and rare diseases, pain, respiratory diseases, and women's health. Evotec SE has a strategic collaboration with the University Hospital Erlangen regarding molecular analyses of biospecimens from the German chronic kidney disease cohort study. The company was founded in 1993 and is headquartered in Hamburg, Germany.
Read More

Today's Range

Now: €36.77
Low: €36.33
High: €37.04

50 Day Range

MA: €34.86
Low: €32.85
High: €37.13

52 Week Range

Now: €36.77
Low: €21.31
High: €43.00


182,753 shs

Average Volume

1,360,000 shs

Market Capitalization

$6.05 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Evotec?

The following equities research analysts have issued stock ratings on Evotec in the last twelve months: Baader Bank, Deutsche Bank Aktiengesellschaft, Royal Bank of Canada, and Warburg Research.
View the latest analyst ratings for EVT.

What is the current price target for Evotec?

4 Wall Street analysts have set twelve-month price targets for Evotec in the last year. Their average twelve-month price target is €36.25, suggesting a possible downside of 1.4%. Warburg Research has the highest price target set, predicting EVT will reach €40.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of €33.00 for Evotec in the next year.
View the latest price targets for EVT.

What is the current consensus analyst rating for Evotec?

Evotec currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EVT will outperform the market and that investors should add to their positions of Evotec.
View the latest ratings for EVT.

What other companies compete with Evotec?

How do I contact Evotec's investor relations team?

Evotec's physical mailing address is Essener Bogen 7, HAMBURG, 22419, Germany. The company's listed phone number is +49-40-560810. The official website for Evotec is